Healthcare is sometimes about life or death, but is almost always about quality of life, says the EVP of health system products and strategy.
Repatha reduces need for time-consuming procedure; Trump selects Gottlieb to lead the FDA; Acorda launches Alexa skill for MS
The health system is one of the largest in the country. Most of Ascension's hospitals, Ragone says, used to operate almost independently from each other and the company's headquarters.
Cleveland Clinic CEO Toby Cosgrove said at the PRWeek Conference that the pharmaceutical industry has a responsibility to manage drug costs without the government stepping in
Mayo Clinic's CEO talks about how a trusted name in healthcare has evolved digitally and centered communications on its newsroom while retaining integrity.
Ascension worked with several Omnicom agencies on the rebranding push, including FleishmanHillard and Siegel & Gale.
Some U.S. hospitals still haven't received Valeant discounts; U.N. General Assembly will discuss antibiotic resistance; AstraZeneca diabetes drugs lowered blood sugar in study
The Cleveland Clinic has launched its first national men's health campaign, MENtion It, to encourage men to be more proactive about their health.
U.S. cancer centers triple spending on advertising; study finds patient choice can reduce side effects; the FDA approves Shire's dry-eye drug
Despite the increasing importance of the CIO post, top technology professionals still find it hard to break into the uppermost ranks at life-sciences companies.
A 69% majority of healthcare organizations said they believe their industry is more vulnerable to data breaches than other business sectors.
Valeant has not delivered promised price breaks on heart drugs; AstraZeneca drug receives orphan status; Allergan promotes Meury and Stewart
The Cleveland Clinic's CEO discusses how he keeps the hospital on top of its game and educates the community it serves.
The Catholic health system worked with FleishmanHillard and GSD&M to create the integrated campaign touting its partnership with the Department of Veterans Affairs.
While it's made great strides, the healthcare industry is still behind in some technology and information safeguards.
The Ketchum veteran joined the nonprofit healthcare system in mid-2014.
Nashville-based ReviveHealth posted $8.7 million in revenue in 2014.
An initial list of consumer health tech deemed essential by MIT and Harvard doctors is short on pharma-backed apps or services.
A nonprofit institute will soon start producing consumer reviews of digital health tools that have been vetted by Harvard clinicians.
Securing market access has become significantly more challenging for pharma marketers.
How to bring an enhanced customer experience to the healthcare industry
In order to reach consumers, hospitals must rethink their old ways of marketing outreach.
By thinking like marketers, chief medical officers can embrace innovation and differentiate their organizations by providing better experiences, better products and ultimately better health.
The company acquired Tea Leaves Health for $30 million to diversify its business.
The focus on boosting physician referrals might appear contrary to the current obsession with patient-centric marketing.
With an eye on the bottom line, hospitals and their marketing firms traditionally haven't spent much time on school campuses.
The academic partnership builds on the company's 2014 collaboration with UCB on using sensors to gather biometric data about people with neurological disorders.
Mylan considers higher bid for Perrigo; Boehringer Ingelheim partners with health system on COPD; EMD Serono's experimental cancer drug gets Fast Track status
AbbVie nabs Pharmacyclics for $21 billion, Mallinckrodt makes a Pfizer-Hospira style acquisition, and the National Cancer Institute's director resigns
Some IDNs are centralizing decisionmaking at the corporate level and other hospitals are limiting on-site access to sales reps.
- Five things for pharma marketers to know: Wednesday, March 22, 2017
- Drugmakers target severe asthma patients with biologics, but payers raise pricing issue
- Novartis aims to bring first oral asthma drug to market in two decades
- What five different pharma marketing careers look like
- Veeva and QuintilesIMS tussle over customer reference data
- 2017 Healthcare Marketers Trend Report: All the data in one place
- Infographic: What's next for the point of care market
- Drugmakers again boost DTC spending, to $5.6 billion in 2016
- Digital IDs become focus as drugmakers seek to track doctors' behavior online
- Some CME experts remain skeptical when it comes to social media